804 Participants Needed

PTSD Screening for Pregnant Women

Recruiting at 1 trial location
AP
Overseen ByAbigail Powers Lott, PhD, ABPP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Brief Screening for PTSD, Culturally Responsive SBIRT for OB for PTSD in pregnant women?

A short-term psychotherapy intervention for PTSD during pregnancy significantly reduced PTSD and depression symptoms in pregnant women, with benefits lasting post-treatment and post-partum. This suggests that brief, targeted interventions can be effective in managing PTSD symptoms in pregnant women.12345

Is the PTSD screening and intervention safe for pregnant women?

The studies reviewed did not report any specific safety concerns related to the PTSD screening and brief intervention for pregnant women. The intervention was successful in reducing PTSD and depression symptoms, suggesting it is generally safe for use in this population.12346

How is the treatment 'Brief Screening for PTSD, Culturally Responsive SBIRT for OB' different from other PTSD treatments for pregnant women?

This treatment is unique because it involves a brief screening tool specifically designed for prenatal care, which is culturally responsive and tailored to diverse, low-income populations. Unlike other treatments, it focuses on early identification of PTSD symptoms during pregnancy, which is often overlooked in standard obstetric care.378910

What is the purpose of this trial?

This study will compare the effectiveness of two active screening interventions in improving post-traumatic stress disorder (PTSD) symptoms, maternal perinatal care utilization, satisfaction utilization of mental healthcare services, and maternal health and birth-related outcomes for Black pregnant women.

Research Team

AL

Abigail Lott, PhD, ABPP

Principal Investigator

Emory University

BW

Briana Woods-Jaeger, PhD

Principal Investigator

Emory University

Eligibility Criteria

This trial is for Black pregnant women who may have PTSD. It's designed to see if certain screening methods can help improve their mental health, satisfaction with care, and birth outcomes.

Inclusion Criteria

Ability to provide informed consent
I am willing to participate in the study.
Self-identification as Black or African American
See 2 more

Exclusion Criteria

Active suicidality

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Intervention

Participants receive either Culturally Responsive SBIRT for OB or Brief Screening for PTSD during their prenatal care visit

Initial OB visit (weeks 1-13)
1 visit (in-person)

Follow-up

Participants are monitored for PTSD symptoms and prenatal care utilization

12 months
4 visits (in-person)

Postpartum Follow-up

Participants are assessed for PTSD symptoms and adequacy of prenatal care utilization 6 weeks postpartum

6 weeks postpartum

Treatment Details

Interventions

  • Brief Screening for PTSD
  • Culturally Responsive SBIRT for OB
Trial Overview The study compares two approaches: a brief screening for PTSD and a culturally responsive SBIRT (Screening, Brief Intervention, and Referral to Treatment) specifically tailored for obstetrics.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Culturally Responsive SBIRT for OBExperimental Treatment1 Intervention
Participants randomized to Culturally Responsive SBIRT for OB will participate in the intervention visit (20-30 minutes) while waiting for their OB visit (or after the visit if time does not allow) and then engage in their prenatal care visit as usual. If any safety concerns emerge during the visit, the lay provider will contact the clinical staff on the study
Group II: Brief Screening for PTSDExperimental Treatment1 Intervention
Participants randomized to Brief Screening For PTSD, screening will be conducted as part of regular clinic activities during the initial prenatal care visit. Specifically, clinic staff (nurse, PA) or study staff will ask the questions in the PC-PTSD-5 along with the standard procedure to administer the Edinburgh Postnatal Depression Scale (EPDS), and the provider will review the results with the patient during the prenatal care visit and provide referral resources regardless of screen outcome. Positive PTSD screens (PC-PTSD-5 ≥ 3) will be referred to the hospital's integrated care team following the same model as positive EPDS screens.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

University of Missouri, Kansas City

Collaborator

Trials
73
Recruited
34,600+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

Findings from Research

In a study of 745 pregnant women at urban health centers, 6.6% were diagnosed with current PTSD, and over half reported experiencing trauma that met PTSD criteria, highlighting the prevalence of trauma in this population.
Women with PTSD were significantly more likely to face additional psychosocial risks, such as housing instability and depression, indicating that PTSD is associated with broader social challenges during pregnancy.
Posttraumatic stress disorder among women receiving prenatal care at three federally qualified health care centers.Kim, HG., Harrison, PA., Godecker, AL., et al.[2021]
The TO-CARE intervention, which combines cognitive-behavioral therapy (CBT) and trauma-sensitive obstetric care, was found to be acceptable to pregnant abuse survivors, with 95% of participants reporting benefits from the program.
While most participants showed some improvement in posttraumatic stress symptoms (PTS), only a small number achieved reliable improvement, highlighting challenges in retention and effectiveness for low-income, ethno-racial minority pregnant women.
A feasibility study of trauma-sensitive obstetric care for low-income, ethno-racial minority pregnant abuse survivors.Stevens, NR., Lillis, TA., Wagner, L., et al.[2022]
The PTSD-PC screening tool was successfully implemented in prenatal care for 1259 women, revealing that 17% screened positive for PTSD, indicating a significant prevalence of PTSD symptoms in this population.
Women with clinical-level PTSD symptoms exhibited more severe trauma histories and mental health issues compared to those with sub-threshold symptoms, highlighting the need for mental health support, as only 25% had previously received treatment.
Screening for Post-traumatic Stress Disorder in Prenatal Care: Prevalence and Characteristics in a Low-Income Population.Wenz-Gross, M., Weinreb, L., Upshur, C.[2021]

References

Posttraumatic stress disorder among women receiving prenatal care at three federally qualified health care centers. [2021]
A feasibility study of trauma-sensitive obstetric care for low-income, ethno-racial minority pregnant abuse survivors. [2022]
Screening for Post-traumatic Stress Disorder in Prenatal Care: Prevalence and Characteristics in a Low-Income Population. [2021]
Engagement in and Benefits of a Short-Term, Brief Psychotherapy Intervention for PTSD During Pregnancy. [2022]
Correlates of Perinatal Post-Traumatic Stress among Culturally Diverse Women with Depressive Symptomatology. [2023]
Screening, Brief Intervention, and Referral to Treatment to Prevent Post-Traumatic Stress Disorder After Gunshot Wounds. [2022]
Feasibility and Utility of Posttraumatic Stress Disorder Screening Among Postpartum Patients at an Urban Safety-Net Institution. [2023]
Trauma exposure and post-traumatic stress disorder in a cohort of pregnant Peruvian women. [2018]
Screening for PTSD during pregnancy: a missed opportunity. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Posttraumatic Stress Disorder, Health Problems, and Depression Among African American Women in Residential Substance Use Treatment. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security